Ranbaxy halts production at 2 plants to tackle its regulatory mess

 

Indian drugmaker says a new board committee is now involved in oversight

February 25, 2014 | By Eric Palmer

Read more: Ranbaxy halts production at 2 plants to tackle its regulatory mess - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/ranbaxy-halts-production-2-plants-tackle-its-regulatory-mess/2014-02-25#ixzz2uOOfx7pE
Subscribe at FiercePharma Manufacturing

The FDA catches another Indian drugmaker falsifying data

Warning letter says USV faked sample weights

February 25, 2014 | By Eric Palmer

Read more: The FDA catches another Indian drugmaker falsifying data - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/fda-catches-another-indian-drugmaker-falsifying-data/2014-02-25#ixzz2uOOJbc3r
Subscribe at FiercePharma Manufacturing

Georgia Supreme Court considers death penalty pain

Should Georgia prison officials tell death row inmates where they bought the drugs that will be used to kill them?
Right now, those officials don't have to reveal their drug supplier -- not to inmates, not to lawyers, not to journalists or activists or anyone else filing a public records request. But the Georgia Supreme Court is considering the question after hearing arguments last week about the potential execution of Warren Lee Hill.
continue to read here

Imprimis Pharmaceuticals' Pre-Commercial Ophthalmic Formulations to be Presented at 2014 American-European Congress of Ophthalmic Surgery (ACOS™)/Dulaney Winter Meeting - Local news, weather, sports Savannah | WSAV On Your Side

Imprimis Pharmaceuticals' Pre-Commercial Ophthalmic Formulations to be Presented at 2014 American-European Congress of Ophthalmic Surgery (ACOS™)/Dulaney Winter Meeting - Local news, weather, sports Savannah | WSAV On Your Side